For example, women with ER-/PR- tumors had a 24% increase in the relative risk of breast cancer mortality with each increase in tumor grade level, whereas women with ER+/PR+ tumors had a 62% elevated mortality risk with each increase in tumor grade level. The gene discussed is ESR1; the disease is breast cancer.